Europeans have found the secret to making some of the world's costliest medicines much more affordable, as much as 80 percent cheaper than in the U.S.
Dec 27, 2018
0
2
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines – but they are also expensive.
Oct 22, 2018
0
3
The American College of Rheumatology (ACR) has published a new white paper, "The Science Behind Biosimilars - Entering a New Era of Biologic Therapy," providing a comprehensive overview of the scientific, clinical, economic ...
Feb 7, 2018
0
4
To address the fear and insecurity expressed by rheumatology patients on being switched from a biologic to a biosimilar treatment for their arthritis, the Danish Rheumatism Association has participated in a national programme ...
Jun 16, 2017
0
1
The Supreme Court is speeding up the time for generic biotech drugs to become available to the public. The court's unanimous ruling Monday means a loss of billions in sales to makers of original versions.
Jun 12, 2017
0
0
Biosimilars create opportunities for sustainable cancer care, says the European Society for Medical Oncology (ESMO) in a position paper published in ESMO Open.1 The document outlines approval standards for biosimilars, how ...
Jan 18, 2017
0
2
